During the past decade, Nagoya University Graduate School of Medicine conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Nagoya University Graduate School of Medicine" #1 sponsor was "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials, followed by "Center for Supporting Hematology-Oncology Trials" with 1 trials sponsored, "Japan Clinical Cancer Research Organization" with 1 trials sponsored, "National Cancer Center Hospital East" with 1 trials sponsored and "Niguarda Hospital" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nagoya University Graduate School of Medicine" #1 collaborator was "Tokyo Medical and Dental University" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator, "Japan Agency for Medical Research and Development" with 1 trials as a collaborator and "Japan Clinical Oncology Group" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 9 trials.

According to Clinical.Site data, the most researched conditions in "Nagoya University Graduate School of Medicine" are "Colorectal Cancer" (2 trials), "Febrile Neutropenia" (1 trials), "Myocarditis Acute" (1 trials), "Rectal Cancer Recurrent" (1 trials) and "Rectal Carcinoma" (1 trials). Many other conditions were trialed in "Nagoya University Graduate School of Medicine" in a lesser frequency.

Most popular intervention types in "Nagoya University Graduate School of Medicine" are "Drug" (6 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "UFT adjuvant chemotherapy" (2 trials), "Chemotherapy" (1 trials), "Methylprednisolone" (1 trials), "Oxaliplatin" (1 trials) and "Preoperative radiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nagoya University Graduate School of Medicine" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Nagoya University Graduate School of Medicine". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Nagoya University Graduate School of Medicine, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nagoya University Graduate School of Medicine, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".